RYLPF
Price
$24.37
Change
+$0.66 (+2.78%)
Updated
Jun 27 closing price
Capitalization
19.18B
SRTS
Price
$4.86
Change
+$0.04 (+0.83%)
Updated
Jun 27 closing price
Capitalization
61.97M
31 days until earnings call
Interact to see
Advertisement

RYLPF vs SRTS

Header iconRYLPF vs SRTS Comparison
Open Charts RYLPF vs SRTSBanner chart's image
Koninklijke Philips N.V
Price$24.37
Change+$0.66 (+2.78%)
Volume$187
Capitalization19.18B
Sensus Healthcare
Price$4.86
Change+$0.04 (+0.83%)
Volume$91.71K
Capitalization61.97M
RYLPF vs SRTS Comparison Chart in %
Loading...
RYLPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RYLPF vs. SRTS commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYLPF is a Hold and SRTS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (RYLPF: $24.37 vs. SRTS: $4.86)
Brand notoriety: RYLPF and SRTS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: RYLPF: 1% vs. SRTS: 114%
Market capitalization -- RYLPF: $19.18B vs. SRTS: $61.97M
RYLPF [@Medical Specialties] is valued at $19.18B. SRTS’s [@Medical Specialties] market capitalization is $61.97M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RYLPF’s FA Score shows that 1 FA rating(s) are green whileSRTS’s FA Score has 1 green FA rating(s).

  • RYLPF’s FA Score: 1 green, 4 red.
  • SRTS’s FA Score: 1 green, 4 red.
According to our system of comparison, RYLPF is a better buy in the long-term than SRTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RYLPF’s TA Score shows that 6 TA indicator(s) are bullish while SRTS’s TA Score has 4 bullish TA indicator(s).

  • RYLPF’s TA Score: 6 bullish, 2 bearish.
  • SRTS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RYLPF is a better buy in the short-term than SRTS.

Price Growth

RYLPF (@Medical Specialties) experienced а +4.96% price change this week, while SRTS (@Medical Specialties) price change was +2.53% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.38%. For the same industry, the average monthly price growth was +1.94%, and the average quarterly price growth was +2.76%.

Reported Earning Dates

SRTS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+2.38% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYLPF($19.2B) has a higher market cap than SRTS($62M). SRTS has higher P/E ratio than RYLPF: SRTS (126.00) vs RYLPF (29.76). RYLPF YTD gains are higher at: -3.501 vs. SRTS (-29.769). SRTS has higher annual earnings (EBITDA): 79K vs. RYLPF (-210M). RYLPF has more cash in the bank: 968M vs. SRTS (23.1M). SRTS has less debt than RYLPF: SRTS (783K) vs RYLPF (8.22B). RYLPF has higher revenues than SRTS: RYLPF (18.4B) vs SRTS (24.4M).
RYLPFSRTSRYLPF / SRTS
Capitalization19.2B62M30,968%
EBITDA-210M79K-265,823%
Gain YTD-3.501-29.76912%
P/E Ratio29.76126.0024%
Revenue18.4B24.4M75,410%
Total Cash968M23.1M4,190%
Total Debt8.22B783K1,049,298%
FUNDAMENTALS RATINGS
RYLPF vs SRTS: Fundamental Ratings
RYLPF
SRTS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
71
Overvalued
PROFIT vs RISK RATING
1..100
10083
SMR RATING
1..100
8686
PRICE GROWTH RATING
1..100
5762
P/E GROWTH RATING
1..100
646
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RYLPF's Valuation (4) in the null industry is significantly better than the same rating for SRTS (71) in the Medical Specialties industry. This means that RYLPF’s stock grew significantly faster than SRTS’s over the last 12 months.

SRTS's Profit vs Risk Rating (83) in the Medical Specialties industry is in the same range as RYLPF (100) in the null industry. This means that SRTS’s stock grew similarly to RYLPF’s over the last 12 months.

SRTS's SMR Rating (86) in the Medical Specialties industry is in the same range as RYLPF (86) in the null industry. This means that SRTS’s stock grew similarly to RYLPF’s over the last 12 months.

RYLPF's Price Growth Rating (57) in the null industry is in the same range as SRTS (62) in the Medical Specialties industry. This means that RYLPF’s stock grew similarly to SRTS’s over the last 12 months.

SRTS's P/E Growth Rating (6) in the Medical Specialties industry is somewhat better than the same rating for RYLPF (64) in the null industry. This means that SRTS’s stock grew somewhat faster than RYLPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RYLPFSRTS
RSI
ODDS (%)
Bullish Trend 4 days ago
66%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
57%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
55%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 4 days ago
60%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
55%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
52%
Bullish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
48%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
60%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RYLPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WOOF2.830.04
+1.43%
Petco Health and Wellness Company
L90.400.36
+0.40%
Loews Corp
TSAT24.04-0.46
-1.88%
Telesat Corp
KOS1.83-0.04
-2.14%
Kosmos Energy Ltd
IBO0.75-0.17
-18.26%
Impact BioMedical Inc.

RYLPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYLPF has been loosely correlated with MTD. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RYLPF jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYLPF
1D Price
Change %
RYLPF100%
+2.78%
MTD - RYLPF
38%
Loosely correlated
-0.73%
CDNA - RYLPF
28%
Poorly correlated
-0.31%
MBGNF - RYLPF
24%
Poorly correlated
N/A
SRTS - RYLPF
23%
Poorly correlated
+0.83%
WRBY - RYLPF
21%
Poorly correlated
+1.91%
More

SRTS and

Correlation & Price change

A.I.dvisor tells us that SRTS and PLSE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRTS and PLSE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRTS
1D Price
Change %
SRTS100%
+0.83%
PLSE - SRTS
31%
Poorly correlated
+1.28%
HAE - SRTS
29%
Poorly correlated
-1.30%
BFLY - SRTS
29%
Poorly correlated
-2.97%
HOLX - SRTS
28%
Poorly correlated
-0.15%
TWST - SRTS
28%
Poorly correlated
-2.73%
More